Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02036190 · ClinicalTrials.gov registry record
Ancillary T Cell Based Studies in SPIROMICS
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 175
- Enrollment target
NCT02036190: Completed study, sponsored by University of California, San Francisco.
NCT02036190 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02036190 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
The long-term objectives of this ancillary application are to characterize a subpopulation of smokers with auto-reactive T cell response, to validate immunodiagnostic assays that could detect emphysema, and to find molecular signatures for pathogenic T cell development in a well-characterized cohort participating in SPIROMICS (UCSF center).
Primary Outcome
We will examine cytokines released by T cells in response to elastin fragments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-01 |
What the finished NCT02036190 record still lists
NCT02036190 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02036190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02036190 about?
NCT02036190 is a clinical study titled "Ancillary T Cell Based Studies in SPIROMICS". The long-term objectives of this ancillary application are to characterize a subpopulation of smokers with auto-reactive T cell response, to validate immunodiagnostic assays that could detect emphysema, and to find molecular signatures for pathogenic T cell development in a well-characterized cohort...
What is the current status of trial NCT02036190?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2012-02. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT02036190?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia